🇺🇸 BUTYRIC ACID in United States
37 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 20 April 2025 – 20 April 2026
- Total reports: 37
Most-reported reactions
- Diarrhoea — 6 reports (16.22%)
- Drug Interaction — 4 reports (10.81%)
- Drug-Induced Liver Injury — 4 reports (10.81%)
- Off Label Use — 4 reports (10.81%)
- Overdose — 4 reports (10.81%)
- Acute Hepatic Failure — 3 reports (8.11%)
- Anxiety — 3 reports (8.11%)
- Bacteraemia — 3 reports (8.11%)
- Blood Pressure Systolic Increased — 3 reports (8.11%)
- Coma Hepatic — 3 reports (8.11%)
BUTYRIC ACID in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is BUTYRIC ACID approved in United States?
BUTYRIC ACID does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for BUTYRIC ACID in United States?
Marketing authorisation holder not available in our data.